Covid-19 roundup: J&J plans 60,000-person PhIII for September; Peter Marks draws a red line
J&J is planning the largest Phase III trial of a Covid-19 vaccine to date, with a goal to enroll 60,000 volunteers to test its adenovirus …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
